BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

Trial StartGalaFLEX LITE™ ScaffoldPositive

AI Analysis

Summary

BD announced that its STANCE trial for GalaFLEX LITE™ Scaffold has surpassed a key enrollment milestone. The trial is evaluating the scaffold's use in breast revision surgery for capsular contracture treatment.

Clinical Trial Data

Outcome Details

STANCE trial surpassed key enrollment milestone

Importance:4/10

Sentiment:

0.60

clinical trialmedical devicetissue regenerationbreast surgeryenrollment milestone

Related Companies

$BDX

Read the original article

Published by PR Newswire Clinical Trials on August 27, 2026 10:50 AM

Read Original